Belgium vs Cyprus: Cause of death, by non-communicable diseases, ages 0-4, female
Belgium
39.1%
in 2021
Cyprus
39.0%
in 2021
Belgium rank
53rd
Cyprus rank
54th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Belgium
- Cyprus
How they compare
Belgium currently reports 39.1% against 39.0% in Cyprus, a difference of 0.1%.
Across all 6 years both countries report, Belgium has been ahead every year.
Belgium ranks 53rd and Cyprus ranks 54th of 185 countries.
Belgium has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belgium | Cyprus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.9% | 43.4% | 2.5% | Belgium |
| 2010s | 41.7% | 34.2% | 7.5% | Belgium |
| 2020s | 39.4% | 39.0% | 0.4% | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Belgium or Cyprus?
- Belgium, at 39.1% against 39.0% in Cyprus as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Belgium and Cyprus?
- 0.1%, with Belgium ahead.
- How many years of comparable data are there for Belgium and Cyprus?
- 6 years are reported by both, from 2000 to 2021.
- How do Belgium and Cyprus rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Belgium ranks 53rd and Cyprus ranks 54th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.